Mountain West AIDS Education and Training Center (MWAETC)

OD presentation return node

« Return to MWAETC On-Demand Presentations

Long-acting IM cabotegravir (CAB) for HIV pre-exposure prophylaxis

Presentation Date: 2020-09-17

Presentation Length: 39:08

Presenters: Raphael J. Landovitz, MD

Presentation Categories: HIV ECHO

Presentation Tags: Pre-Exposure Prophylaxis (PrEP)

Presentation Slides:

Download (225.480 KB)

Presentation Downloads:

Related Documents:

Related Links:

Related Presentations:

Presentation Details:
Dr. Raphael Landovitz discusses findings and implications of the HPTN 083 study, which compared injectable long-acting intramuscular cabotegagravir to oral emtricitabine-tenofovir DF (Truvada) for HIV pre-exposure prophylaxis (PrEP) for high-risk men who have sex with men (MSM) and transgender women.

Presentation Transcript:

MOUNTAIN WEST AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,982,063 with 0% financed with non-governmental sources. The content in presentations are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.